Angiotensin II and norepinephrine activate specific calcineurin-dependent NFAT transcription factor isoforms in cardiomyocytes

Journal of Applied Physiology

Volumn 111, Issue 5, 2011, Pages 1278-1289

  Lunde, Ida G ^a,b   Kvaløy, Heidi ^a,b   Austbø, Bjørg ^a,b   Christensen, Geir ^a,b   Carlson, Cathrine R ^a,b  

^a ULLEVÅL UNIVERSITY HOSPITAL   (Norway)

^b UNIVERSITY OF OSLO   (Norway)

Author keywords

Calcineurin; Cardiac hypertrophy; Nuclear factor of activated T cell isoforms

Indexed keywords

ANGIOTENSIN II; CALCINEURIN; CALCIUM; DNA BINDING PROTEIN; ISOPROTEIN; NORADRENALIN; TRANSCRIPTION FACTOR NFAT;

AMINO ACID SEQUENCE; ANIMAL; ARTICLE; C57BL MOUSE; DRUG EFFECT; EPITOPE MAPPING; HEART MUSCLE CELL; METABOLISM; METHODOLOGY; MOLECULAR GENETICS; MOUSE; NULL CELL; PROTEIN SYNTHESIS; SIGNAL TRANSDUCTION;

AMINO ACID SEQUENCE; ANGIOTENSIN II; ANIMALS; CALCINEURIN; CALCIUM; DNA-BINDING PROTEINS; EPITOPE MAPPING; LYMPHOCYTES, NULL; MICE; MICE, INBRED C57BL; MOLECULAR SEQUENCE DATA; MYOCYTES, CARDIAC; NFATC TRANSCRIPTION FACTORS; NOREPINEPHRINE; PROTEIN BIOSYNTHESIS; PROTEIN ISOFORMS; SIGNAL TRANSDUCTION;

EID: 81355132744     PISSN: 87507587     EISSN: 15221601     Source Type: Journal    
DOI: 10.1152/japplphysiol.01383.2010     Document Type: Article

References (52)

1. Abbasi S, Su B, Kellems RE, Yang J, Xia Y. The essential role of MEKK3 signaling in angiotensin II-induced calcineurin/nuclear factor of activated T-cells activation. J Biol Chem 280: 36737-36746, 2005. (Pubitemid 41587753)
2. Adams JW, Sakata Y, Davis MG, Sah VP, Wang Y, Liggett SB, Chien KR, Brown JH, Dorn GW. Enhanced Galphaq signaling: a common pathway mediates cardiac hypertrophy and apoptotic heart failure. Proc Natl Acad Sci USA 95: 10140-10145, 1998. (Pubitemid 28415308)
3. Adams KFJ. Pathophysiologic role of the renin-angiotensin-aldosterone and sympathetic nervous systems in heart failure. Am J Health Syst Pharm 61: S4-S13, Suppl 2, 2004.
4. Akhter SA, Luttrell LM, Rockman HA, Iaccarino G, Lefkowitz RJ, Koch WJ. Targeting the receptor-Gq interface to inhibit in vivo pressure overload myocardial hypertrophy. Science 280: 574-577, 1998. (Pubitemid 28227758)
5. Beals CR, Clipstone NA, Ho SN, Crabtree GR. Nuclear localization of NF-ATc by a calcineurin-dependent, cyclosporin-sensitive intramolecular interaction. Genes Dev 11: 824-834, 1997. (Pubitemid 27175290)
6. Bourajjaj M, Armand AS, da Costa Martins PA, Weijts B, van der Nagel R, Heeneman S, Wehrens XH, De Windt LJ. NFATc2 is a necessary mediator of calcineurin-dependent cardiac hypertrophy and heart failure. J Biol Chem 283: 22295-22303, 2008.
7. Bueno OF, van Rooij E, Molkentin JD, Doevendans PA, De Windt LJ. Calcineurin and hypertrophic heart disease: novel insights and remaining questions. Cardiovasc Res 53: 806-821, 2002. (Pubitemid 34261019)
8. Bueno OF, Wilkins BJ, Tymitz KM, Glascock BJ, Kimball TF, Lorenz JN. Impaired cardiac hypertrophic response in calcineurin Abeta-deficient mice. Proc Natl Acad Sci USA 99: 4586-4591, 2002. (Pubitemid 34286028)
9. Calabria E, Ciciliot S, Moretti I, Garcia M, Picard A, Dyar KA, Pallafacchina G, Tothova J, Schiaffino S, Murgia M. NFAT isoforms control activity-dependent muscle fiber type specification. Proc Natl Acad Sci USA 106: 13335-13340 2009.
10. Chien KR, Knowlton KU, Zhu H, Chien S. Regulation of cardiac gene expression during myocardial growth and hypertrophy: molecular studies of an adaptative physiologic response. FASEB J 5: 3037-3046, 1991. (Pubitemid 21892863)
11. Cikos S, Bukovská A, Koppel J. Relative quantification of mRNA: comparison of methods currently used for real-time PCR data analysis. BMC Mol Biol 8: 113, 2007.
12. Clerk A, Sugden PH. Activation of protein kinase cascades in the heart by hypertrophic G protein-coupled receptor agonists. Am J Cardiol 83: 64H-69H, 1999. (Pubitemid 29330931)
13. Colella M, Grisan F, Robert V, Turner JD, Thomas AP, Pozzan T. Ca2 oscillation frequency decoding in cardiac cell hypertrophy: role of calcineurin/NFAT as Ca2 signal integrators. Proc Natl Acad Sci USA 105: 2859-2864, 2008. (Pubitemid 351723634)
14. Colella M, Pozzan T. Cardiac cell hypertrophy in vitro: role of calcineurin/ NFAT as Ca2 signal integrators. Ann NY Acad Sci 1123: 64-68, 2008. (Pubitemid 351431304)
15. Colucci WS. The effects of norepinephrine on myocardial biology: implications for the therapy of heart failure. Clin Cardiol 21: I20-I24, 1998. (Pubitemid 28553939)
16. D'Angelo DD, Sakata Y, Lorenz JN, Boivin GP, Walsh RA, Liggett SB, Dorn GW. Transgenic Galphaq overexpression induces cardiac contractile failure in mice. Proc Natl Acad Sci USA 94: 8121-8126, 1997. (Pubitemid 27343787)
17. de la Pompa JL, Timmerman LA, Takimoto H, Yoshida H, Elia AJ, Samper E, Potter J, Wakeham A, Marengere L, Langille BL, Crabtree GR, Mak TW. Role of the NF-ATc transcription factor in morphogenesis of cardiac valves and septum. Nature 392: 182-186, 1998. (Pubitemid 28162791)
18. Deng XF, Rokosh DG, Simpson PC. Autonomous and growth factorinduced hypertrophy in cultured neonatal mouse cardiac myocytes. Comparison with rat. Circ Res 87: 781-788, 2000.
19. Diedrichs H, Chi M, Boelck B, Mehlhorn U, Schwinger RH. Increased regulatory activity of the calcineurin/NFAT pathway in human heart failure. Eur J Heart Fail 6: 3-9, 2004. (Pubitemid 38169598)
20. Diedrichs H, Hagemeister J, Chi M, Boelck B, Müller-Ehmsen J, Schneider CA. Activation of the calcineurin/NFAT signaling cascade starts early in human hypertrophic myocardium. J Int Med Res 35: 803-818, 2007. (Pubitemid 350238414)
21. Esposito G, Rapacciuolo A, Naga Prasad SV, Rockman HA. Cardiac hypertrophy: role of G protein-coupled receptors. J Card Fail 8: S409-S414, 2002. (Pubitemid 36083092)
22. Fan G, Jiang YP, Lu Z, Martin DW, Kelly DJ, Zuckerman JM, Ballou LM, Cohen IS, Lin RZ. A transgenic mouse model of heart failure using inducible Galpha q. J Biol Chem 280: 40337-40346, 2005. (Pubitemid 41779171)
23. Frank R. Spot-synthesis-an easy technique for the positionally addressable, parallel chemical synthesis on a membrane support. Tetrahedron 48: 9217-9232, 1992.
24. Halvorsen B, Ranheim T, Nenseter MS, Huggett AC, Drevon CA. Effect of a coffee lipid (cafestol) on cholesterol metabolism in human skin fibroblasts. J Lipid Res 39: 901-912, 1998. (Pubitemid 28163290)
25. Harris DM, Cohn HI, Pesant S, Eckhart AD. GPCR signalling in hypertension: role of GRKs. Clin Sci (Lond) 115: 79-89, 2008.
26. Heinecke J, Molkentin JD. Regulation of cardiac hypertrophy by intracellular signalling pathways. Nat Rev Mol Cell Biol 7: 589-600, 2006. (Pubitemid 44325350)
27. Hodge MR, Ranger AM, de la Brousse FC, Hoey T, Grusby MJ, Glimcher LH. Hyperproliferation and dysregulation of IL-4 expression in NF-ATp-deficient mice. Immunity 4: 397-405, 1996. (Pubitemid 26174981)
28. Hoey T, Sun YL, Williamson K, Xu X. Isolation of two new members of the NF-AT gene family and functional characterization of the NF-AT proteins. Immunity 2: 461-475, 1995.
29. Hogan PG, Chen L, Nardone J, Rao A. Transcriptional regulation by calcium, calcineurin, and NFAT. Genes Dev 17: 2205-2232, 2003. (Pubitemid 37128637)
30. Hunton DL, Lucchesi PA, Pang Y, Cheng X, Dell'Italia LJ, Marchase RB. Capacitative calcium entry contributes to nuclear factor of activated T-cells nuclear translocation and hypertrophy in cardiomyocytes. J Biol Chem 277: 14266-14273, 2002. (Pubitemid 34968041)
31. Ivery MT. A proposed molecular model for the interaction of calcineurin with the cyclosporin A-cyclophilin A complex. Bioorg Med Chem 7: 1389-1402, 1999. (Pubitemid 29292379)
32. Kang M, Chung KY, Walker JW. G-protein coupled receptor signaling in myocardium: not for the faint of heart. Physiology (Bethesda) 22: 174-184, 2007.
33. Larsen KO, Lygren B, Sjaastad I, Krobert KA, Arnkvaern K, Florholmen G, Larsen AK, Levy FO, Taskén K, Skjønsberg OH, Christensen G. Diastolic dysfunction in alveolar hypoxia: a role for interleukin-18-mediated increase in protein phosphatase 2A. Cardiovasc Res 80: 47-54, 2008.
34. Lim HW, De Windt LJ, Steinberg L, Taigen T, Witt SA, Kimball TR, Molkentin JD. Calcineurin expression, activation, and function in cardiac pressure-overload hypertrophy. Circulation 101: 2431-2437, 2000. (Pubitemid 30329136)
35. Lim HW, Molkentin JD. Calcineurin and human heart failure. Nat Med 5: 246-247, 1999.
36. Mende U, Kagen A, Cohen A, Aramburu J, Schoen FJ, Neer EJ. Transient cardiac expression of constitutively active Galphaq leads to hypertrophy and dilated cardiomyopathy by calcineurin-dependent and independent pathways. Proc Natl Acad Sci USA 95: 13893-13893, 1998.
37. Molkentin JD, Lu JR, Antos CL, Markham B, Richardson J, Robbins J, Grant SR, Olson EN. A calcineurin-dependent transcriptional pathway for cardiac hypertrophy. Cell 93: 215-228, 1998. (Pubitemid 28180855)
38. Palomeque J, Delbridge L, Petroff MV. Angiotensin II: a regulator of cardiomyocyte function and survival. Front Biosci 14: 5118-5133, 2009.
39. Pu WT, Ma Q, Izumo S. NFAT transcription factors are critical survival factors that inhibit cardiomyocyte apoptosis during phenylephrine stimulation in vitro. Circ Res 92: 725-731, 2003. (Pubitemid 36457636)
40. Ranger AM, Grusby MJ, Hodge MR, Gravallese EM, de la Brousse FC, Hoey T, Mickanin C, Baldwin HS, Glimcher LH. The transcription factor NF-ATc is essential for cardiac valve formation. Nature 392: 186-190, 1998. (Pubitemid 28162792)
41. Rao A, Luo C, Hogan PG. Transcription factors of the NFAT family: regulation and function. Annu Rev Immunol 15: 707-747, 1997. (Pubitemid 27169297)
42. Rinne A, Blatter LA. Activation of NFATc1 is directly mediated by IP3 in adult cardiomyocytes. Am J Physiol Heart Circ Physiol 299: H1701-H1707, 2010.
43. Rinne A, Kapur N, Molkentin JD, Pogwizd SM, Bers DM, Banach K, Blatter LA. Isoform-and tissue-specific regulation of the Ca2-sensitive transcription factor NFAT in cardiac myocytes and in heart failure. Am J Physiol Heart Circ Physiol 298: H2001-H2009, 2010.
44. Rockman HA, Koch WJ, Lefkowitz RJ. Seven-transmembrane-spanning receptors and heart function. Nature 415: 206-212, 2002. (Pubitemid 34059526)
45. Salazar NC, Chen J, Rockman HA. Cardiac GPCRs: GPCR signaling in healthy and failing hearts. Biochim Biophys Acta 1768: 1006-1018, 2007. (Pubitemid 46463942)
46. Shen T, Liu Y, Cseresnyés Z, Hawkins A, Randall WR, Schneider MF. Activity-and calcineurin-independent nuclear shuttling of NFATc1, but not NFATc3, in adult skeletal muscle fibers. Mol Biol Cell 17: 1570-1582, 2006. (Pubitemid 44011577)
47. Soto-Nieves N, Puga I, Abe BT, Bandyopadhyay S, Baine I, Rao A, Macian F. Transcriptional complexes formed by NFAT dimers regulate the induction of T cell tolerance. J Exp Med 206: 867-876, 2009.
48. Van Rooij E, Doevendans PA, de Theije CC, Babiker FA, Molkentin JD, De Windt LJ. Requirement of nuclear factor of activated t-cells in calcineurin-mediated cardiomyocyte hypertrophy. J Biol Chem 277: 48617-48626, 2002. (Pubitemid 35470824)
49. Wang L, Wang C, Lin Y, WXi Y, Zhang W, Zhao Y, Li H, Tian Y, Lv Y, Yang B, Xu C. Involvement of calcium-sensing receptor in cardiac hypertrophyinduced by angiotensinII through calcineurin pathway in cultured neonatal rat cardiomyocytes. Biochem Biophys Res Commun 369: 584-589, 2008.
50. Wilkins BJ, Dai YS, Bueno OF, Xu SAP, Plank DM, Jones F, Kimball TR, Molkentin JD. Calcineurin/NFAT coupling participates in pathological, but not physiological, cardiac hypertrophy. Circ Res 94: 110-118, 2004. (Pubitemid 38064105)
51. Wilkins BJ, De Windt LJ, Bueno OF, Braz JC, Glascock BJ, Kimball TR, Molkentin JD. Targeted disruption of NFATc3, but not NFATc4, reveals an intrinsic defect in calcineurin-mediated cardiac hypertrophic growth. Mol Cell Biol 22: 7603-7613, 2002.
52. Wilkins BJ, Molkentin JD. Calcium-calcineurin signaling in the regulation of cardiac hypertrophy. Biochem Biophys Res Commun 322: 1178-1191, 2004. (Pubitemid 39164648)